• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依洛马司他P'1位同时存在不饱和键和长烷基链,分子模拟研究表明,这使其对明胶酶A(MMP - 2)的抑制作用比对明胶酶B(MMP - 9)的抑制作用更具选择性。

Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.

作者信息

Moroy Gautier, Denhez Clément, El Mourabit Haquima, Toribio Alix, Dassonville Alexandra, Decarme Martine, Renault Jean-Hugues, Mirand Catherine, Bellon Georges, Sapi Janos, Alix Alain J P, Hornebeck William, Bourguet Erika

机构信息

Laboratoire de Spectroscopies et Structures Biomoléculaires (LSSBM), Faculté des Sciences, IFR53 Biomolécules, Université de Reims-Champagne-Ardenne, BP 1039, 51687 Reims Cedex 2, France.

出版信息

Bioorg Med Chem. 2007 Jul 15;15(14):4753-66. doi: 10.1016/j.bmc.2007.05.001. Epub 2007 May 6.

DOI:10.1016/j.bmc.2007.05.001
PMID:17512742
Abstract

Structural analogues of Ilomastat (Galardin), containing unsaturation(s) and chain extension carrying bulky phenyl group or alkyl moieties at P'1 were synthesized and purified by centrifugal partition chromatography. They were analyzed for their inhibitory capacity towards MMP-1, MMP-2, MMP-3, MMP-9 and MMP-14, main endopeptidases involved in tumour progression. Presence of unsaturation(s) decreased the inhibitory potency of compounds but, in turn increased their selectivity for gelatinases. 2b and 2d derivatives with a phenyl group inhibited preferentially MMP-9 with IC50 equal to 45 and 38 nM, respectively, but also display activity against MMP-2 (IC50 equal to 280 and 120 nM, respectively). Molecular docking computations confirmed affinity of these substances for both gelatinases. With aims to obtain a specific gelatinase A (MMP-2) inhibitor, P'1 of Ilomastat was modified to carry one unsaturation coupled to an alkyl chain with pentylidene group. Docking studies indicated that MMP-2, but not MMP-9, could accommodate such substitution; indeed 2a proved to inhibit MMP-2 (IC50=123 nM), while displaying no inhibitory capacity towards MMP-9.

摘要

合成了伊洛马司他(加拉迪恩)的结构类似物,其在P'1处含有不饱和键以及带有庞大苯基或烷基部分的链延长结构,并通过离心分配色谱法进行纯化。分析了它们对MMP-1、MMP-2、MMP-3、MMP-9和MMP-14的抑制能力,这些是参与肿瘤进展的主要内肽酶。不饱和键的存在降低了化合物的抑制效力,但反过来增加了它们对明胶酶的选择性。带有苯基的2b和2d衍生物优先抑制MMP-9,IC50分别等于45和38 nM,但也对MMP-2显示活性(IC50分别等于280和120 nM)。分子对接计算证实了这些物质对两种明胶酶的亲和力。为了获得一种特异性的明胶酶A(MMP-2)抑制剂,对伊洛马司他的P'1进行修饰,使其带有一个与带有亚戊基的烷基链相连的不饱和键。对接研究表明,MMP-2能够容纳这种取代,而MMP-9则不能;事实上,2a被证明可以抑制MMP-2(IC50 = 123 nM),而对MMP-9没有抑制能力。

相似文献

1
Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.依洛马司他P'1位同时存在不饱和键和长烷基链,分子模拟研究表明,这使其对明胶酶A(MMP - 2)的抑制作用比对明胶酶B(MMP - 9)的抑制作用更具选择性。
Bioorg Med Chem. 2007 Jul 15;15(14):4753-66. doi: 10.1016/j.bmc.2007.05.001. Epub 2007 May 6.
2
Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity.将4-(4-溴苯基)苯磺酰基引入伊洛马司他的酰肼类似物中可得到具有更高选择性的强效明胶酶B(基质金属蛋白酶-9)抑制剂。
Bioorg Med Chem. 2008 Sep 15;16(18):8745-59. doi: 10.1016/j.bmc.2008.07.041. Epub 2008 Jul 20.
3
Amber force field implementation, molecular modelling study, synthesis and MMP-1/MMP-2 inhibition profile of (R)- and (S)-N-hydroxy-2-(N-isopropoxybiphenyl-4-ylsulfonamido)-3-methylbutanamides.(R)-和(S)-N-羟基-2-(N-异丙氧基联苯-4-基磺酰胺基)-3-甲基丁酰胺的琥珀色力场实现、分子建模研究、合成及MMP-1/MMP-2抑制谱
Bioorg Med Chem. 2006 Jun 15;14(12):4260-76. doi: 10.1016/j.bmc.2006.01.056. Epub 2006 Feb 17.
4
Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitors.作为选择性明胶酶抑制剂的手性2-(4-苯氧基苯基磺酰甲基)硫杂环丙烷的合成。
Org Lett. 2005 Sep 29;7(20):4463-5. doi: 10.1021/ol0517269.
5
Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.基于异羟肟酸的基质金属蛋白酶2肽抑制剂
Biochimie. 2005 Mar-Apr;87(3-4):385-92. doi: 10.1016/j.biochi.2004.09.008.
6
A combined molecular modeling study on gelatinases and their potent inhibitors.基于胶朊酶及其有效抑制剂的联合分子建模研究。
J Comput Chem. 2010 Jan 15;31(1):24-42. doi: 10.1002/jcc.21279.
7
Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.基于磷酰胺的异羟肟酸作为基质金属蛋白酶抑制剂的设计与合成
J Med Chem. 1999 Jan 14;42(1):87-94. doi: 10.1021/jm980142s.
8
Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases.一种用于基质金属蛋白酶成像的新型荧光光探针的合成与评价
Bioconjug Chem. 2008 May;19(5):1001-8. doi: 10.1021/bc700409j. Epub 2008 Apr 9.
9
MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.基质金属蛋白酶抑制剂:对基质金属蛋白酶-2的选择性抑制作用强于基质金属蛋白酶-3的新型琥珀酰异羟肟酸酯
Bioorg Med Chem Lett. 2003 Sep 1;13(17):2843-6. doi: 10.1016/s0960-894x(03)00590-0.
10
Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.新型磺酰基吡咯烷衍生物作为基质金属蛋白酶抑制剂的合成
Bioorg Med Chem. 2008 Sep 1;16(17):7932-8. doi: 10.1016/j.bmc.2008.07.073. Epub 2008 Jul 30.

引用本文的文献

1
Design and Synthesis of Hydroxamate-Based Matrix Metalloproteinase-2 Inhibitors for Anti-Photoaging.用于抗光老化的基于异羟肟酸酯的基质金属蛋白酶-2抑制剂的设计与合成
J Microbiol Biotechnol. 2025 Feb 10;35:e2412027. doi: 10.4014/jmb.2412.12027.
2
The impact of ionization States of matrix metalloproteinase inhibitors on docking-based inhibitor design.基质金属蛋白酶抑制剂的电离状态对基于对接的抑制剂设计的影响。
ACS Med Chem Lett. 2011 Mar 29;2(6):455-60. doi: 10.1021/ml200031m. eCollection 2011 Jun 9.